Ed340hp
Distinguished member
- Joined
- Jun 28, 2015
- Messages
- 120
- Reason
- PALS
- Diagnosis
- 05/2015
- Country
- US
- State
- California
- City
- Long Beach
I finished the Tirasemtiv Clinical Trial.
Two weeks open label, to test reactions.
48 weeks double-blind trial.
An extra two weeks due to scheduling.
My breathing numbers have not dropped for the past 24 weeks, and my leg and arm strength improved over the past 18 weeks (slightly). My small muscles that have more atrophy (hand & foot paralysis in one or more direction of movement) do not feel to have improved on the muscles with the most paralysis, but where I can initiate movement the range of motion and strength feels not much worse than 24 weeks ago. The clinical trial instruments that measure force in kg verify the slightly improved strength in the larger arm & leg muscles.
I felt good enough the past month to use my recumbent indoor bicycle, starting a quarter-mile at the easiest #1 effort, in mid-March. I can now handle #3 for a half-mile, and another half-mile (or more) cool down easy spin at #1 (yes, #3 of #1-#27 effort). Not an everyday thing, and nothing like my 50 miles a week three years ago, but it is something to keep my spirits up. I pay with sore and uneasy muscles over the next few days of rest, if I push too much, but climbing steps is easier and knee-locking pain is less over these past weeks (as is some reduced uneasiness). I can push my wheelchair or a shopping cart further between rests.
Balance remains poor and I still have the occasional unexpected random delay or failure in muscle response, or dragging a foot/toe (the unchanged asymmetric paralysis of small muscles that does not seem to improve). Any trip or fall reinforces the need to be careful because the neuron death symptoms and progression remain unchanged. This is what is hard to communicate, the muscles sometimes simply don't move when called upon, and the small muscle movements that coordinate balance and dexterity are not reliable. There is no conscious feedback to warn you that the coordinated muscle did not get a signal, before a leg, foot, or arm buckles (and you go down, or hug a wall, or hang off the shopping cart handle). Late day fatigue just makes everything worse, but the presence of soreness does not seem to be much of a factor (fatigue comes every afternoon: exercising, lazy, or somewhere in between).
I apparently suffer slow progress with neuron death, and symptoms progress slow enough to notice a failure in neuron communication as the muscles atrophy. The neuron mortality progress remains relentless. Being sporadic, with my DNA not matching a familial sequence, I am unlikely to see a Clinical Trail for gene therapy as they rightfully target and trial one of the known familial gene sequences for splicing as the science matures. A symptom treatment may be the only option for my time, unless funding and research accelerates to include a shotgun gene splice effort for sporadic PALS (unlikely with current FDA protocols).
I now have four weeks of detox, to empty any residual Tirasemtiv from my system, before I start being assured I get the drug. They say the drug's muscle effects may last the four weeks. I hope so, because I prefer the stability of the past 20-odd weeks.
After detox they will start with the minimum 125mg dose for two weeks, and add an extra 125mg to the dose every two weeks moving forward until I reach the full maximum dose of 500mg/day (or level out, where & if I have an adverse reaction).
Tirasemtiv is not a neuron treatment, but as a muscle treatment it may have promise to keep some of us breathing without aids for more than a few extra months as we progress.
Two weeks open label, to test reactions.
48 weeks double-blind trial.
An extra two weeks due to scheduling.
My breathing numbers have not dropped for the past 24 weeks, and my leg and arm strength improved over the past 18 weeks (slightly). My small muscles that have more atrophy (hand & foot paralysis in one or more direction of movement) do not feel to have improved on the muscles with the most paralysis, but where I can initiate movement the range of motion and strength feels not much worse than 24 weeks ago. The clinical trial instruments that measure force in kg verify the slightly improved strength in the larger arm & leg muscles.
I felt good enough the past month to use my recumbent indoor bicycle, starting a quarter-mile at the easiest #1 effort, in mid-March. I can now handle #3 for a half-mile, and another half-mile (or more) cool down easy spin at #1 (yes, #3 of #1-#27 effort). Not an everyday thing, and nothing like my 50 miles a week three years ago, but it is something to keep my spirits up. I pay with sore and uneasy muscles over the next few days of rest, if I push too much, but climbing steps is easier and knee-locking pain is less over these past weeks (as is some reduced uneasiness). I can push my wheelchair or a shopping cart further between rests.
Balance remains poor and I still have the occasional unexpected random delay or failure in muscle response, or dragging a foot/toe (the unchanged asymmetric paralysis of small muscles that does not seem to improve). Any trip or fall reinforces the need to be careful because the neuron death symptoms and progression remain unchanged. This is what is hard to communicate, the muscles sometimes simply don't move when called upon, and the small muscle movements that coordinate balance and dexterity are not reliable. There is no conscious feedback to warn you that the coordinated muscle did not get a signal, before a leg, foot, or arm buckles (and you go down, or hug a wall, or hang off the shopping cart handle). Late day fatigue just makes everything worse, but the presence of soreness does not seem to be much of a factor (fatigue comes every afternoon: exercising, lazy, or somewhere in between).
I apparently suffer slow progress with neuron death, and symptoms progress slow enough to notice a failure in neuron communication as the muscles atrophy. The neuron mortality progress remains relentless. Being sporadic, with my DNA not matching a familial sequence, I am unlikely to see a Clinical Trail for gene therapy as they rightfully target and trial one of the known familial gene sequences for splicing as the science matures. A symptom treatment may be the only option for my time, unless funding and research accelerates to include a shotgun gene splice effort for sporadic PALS (unlikely with current FDA protocols).
I now have four weeks of detox, to empty any residual Tirasemtiv from my system, before I start being assured I get the drug. They say the drug's muscle effects may last the four weeks. I hope so, because I prefer the stability of the past 20-odd weeks.
After detox they will start with the minimum 125mg dose for two weeks, and add an extra 125mg to the dose every two weeks moving forward until I reach the full maximum dose of 500mg/day (or level out, where & if I have an adverse reaction).
Tirasemtiv is not a neuron treatment, but as a muscle treatment it may have promise to keep some of us breathing without aids for more than a few extra months as we progress.